117 related articles for article (PubMed ID: 36202742)
1. Antenatal magnesium sulphate and delayed passage of meconium: A multicentre study.
Toledano Revenga J; Peña-Moreno A; Arriaga-Redondo M; Márquez Isidro EM; Gochi Valdovinos A; Blanco Bravo D; Sánchez Luna M
An Pediatr (Engl Ed); 2022 Dec; 97(6):383-389. PubMed ID: 36202742
[TBL] [Abstract][Full Text] [Related]
2. Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns.
Gochi Valdovinos A; Arriaga-Redondo M; Dejuan Bitriá E; Pérez Rodríguez I; Márquez Isidro E; Blanco Bravo D
An Pediatr (Engl Ed); 2022 Feb; 96(2):138-144. PubMed ID: 35131219
[TBL] [Abstract][Full Text] [Related]
3. [Prenatal treatment with magnesium sulphate: Initial clinical outcomes in pre-term infants less than 29 weeks and correlation with neonatal magnesium levels].
García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR
An Pediatr (Barc); 2017 Mar; 86(3):135-141. PubMed ID: 27282203
[TBL] [Abstract][Full Text] [Related]
4. [Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns].
Gochi Valdovinos A; Arriaga-Redondo M; Dejuan Bitriá E; Pérez Rodríguez I; Márquez Isidro E; Blanco Bravo D
An Pediatr (Engl Ed); 2020 Dec; ():. PubMed ID: 33358528
[TBL] [Abstract][Full Text] [Related]
5. Increased Risk of Meconium-Related Ileus in Extremely Premature Infants Exposed to Antenatal Magnesium Sulfate.
Sung SI; Ahn SY; Choi SJ; Oh SY; Roh CR; Yang M; Chang YS; Park WS
Neonatology; 2022; 119(1):68-76. PubMed ID: 35016173
[TBL] [Abstract][Full Text] [Related]
6. Lack of Evidence for Time or Dose Relationship between Antenatal Magnesium Sulfate and Intestinal Injury in Extremely Preterm Neonates.
Mikhael M; Bronson C; Zhang L; Curran M; Rodriguez H; Bhakta KY
Neonatology; 2019; 115(4):371-378. PubMed ID: 30965340
[TBL] [Abstract][Full Text] [Related]
7. Antenatal magnesium sulfate and the need for mechanical ventilation in the first three days of life.
Okito O; Aromolaran A; Massa-Buck B; Abdelatif D; Aly H; Mohamed MA
Pediatr Neonatol; 2023 Nov; 64(6):644-650. PubMed ID: 37280122
[TBL] [Abstract][Full Text] [Related]
8. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
9. Effect of perinatal factors on time of first stool passage in preterm newborns: An open, prospective study.
Gulcan H; Gungor S; Tiker F; Kilicdag H
Curr Ther Res Clin Exp; 2006 May; 67(3):214-25. PubMed ID: 24678097
[TBL] [Abstract][Full Text] [Related]
10. Prenatal Therapy with Magnesium Sulfate and Its Correlation with Neonatal Serum Magnesium Concentration.
García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR
Am J Perinatol; 2018 Jan; 35(2):170-176. PubMed ID: 28854447
[TBL] [Abstract][Full Text] [Related]
11. Effects of magnesium sulfate in a newborn piglet meconium aspiration model.
Barrington KJ; Ryan CA; Finer NN
J Perinatol; 2000 Sep; 20(6):373-8. PubMed ID: 11002877
[TBL] [Abstract][Full Text] [Related]
12. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
[TBL] [Abstract][Full Text] [Related]
13. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Antenatal Magnesium Sulfate for Neuroprotection in Extreme Prematurity: A Comparative Observational Study.
Bansal V; Desai A
J Obstet Gynaecol India; 2022 Aug; 72(Suppl 1):36-47. PubMed ID: 34393393
[TBL] [Abstract][Full Text] [Related]
15. Maternal and postnatal hypermagnesemia and the meconium plug syndrome.
Cooney DR; Rosevear W; Grosfeld JL
J Pediatr Surg; 1976 Apr; 11(2):167-72. PubMed ID: 944258
[TBL] [Abstract][Full Text] [Related]
16. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
[TBL] [Abstract][Full Text] [Related]
17. [Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection].
Lloreda-Garcia JM; Lorente-Nicolás A; Bermejo-Costa F; Martínez-Uriarte J; López-Pérez R
Rev Chil Pediatr; 2016; 87(4):261-7. PubMed ID: 26778008
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
Marret S; Ancel PY
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
[TBL] [Abstract][Full Text] [Related]
19. Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
Narasimhulu D; Brown A; Egbert NM; Rojas M; Haberman S; Bhutada A; Minkoff H; Rastogi S
J Perinatol; 2017 Dec; 37(12):1297-1303. PubMed ID: 28981078
[TBL] [Abstract][Full Text] [Related]
20. Hypermagnesemia and feeding intolerance in preterm infants: A cohort study.
Junqueira EO; Marba STM; Caldas JPS
JPEN J Parenter Enteral Nutr; 2022 Jul; 46(5):1054-1060. PubMed ID: 35084777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
